[Anti-CD22 CAR-T combined with anti-CD19 CAR-T cells in the treatment of relapsed or refractory acute B lymphocytic leukemia with severe cytokine release syndrome: two cases report and literature review]

Zhonghua Xue Ye Xue Za Zhi. 2019 Sep 14;40(9):780-782. doi: 10.3760/cma.j.issn.0253-2727.2019.09.016.
[Article in Chinese]
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antigens, CD19
  • Automobiles
  • Cytokine Release Syndrome* / complications
  • Humans
  • Immunotherapy, Adoptive
  • Leukemia, B-Cell* / complications
  • Receptors, Antigen, T-Cell
  • Sialic Acid Binding Ig-like Lectin 2
  • T-Lymphocytes

Substances

  • Antigens, CD19
  • CD22 protein, human
  • Receptors, Antigen, T-Cell
  • Sialic Acid Binding Ig-like Lectin 2

Grants and funding

基金项目：国际自然科学基金（81700126）；湖北省技术创新专项重点项目（2018ACA140）